Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lanyi Nora Chen
Observed names:
Lanyi Chen,
Lanyi N. Chen
Institutions:
NewYork–Presbyterian Hospital,
Columbia University Irving Medical Center
Observed institutions:
NewYork–Presbyterian Hospital,
Columbia University Irving Medical Center,
Herbert Irving Comprehensive Cancer Center,
Columbia University,
University of Pennsylvania
ORCID:
0000-0002-7160-0690
Observed ORCID:
0000-0002-7160-0690
OpenAlex ID:
A5089601125
Works
25
Awards
1
Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From EGFR and ALK Oncogene–Driven Non–Small Cell Lung Cancer (TURBO-NSCLC)
2024
·
Luke R.G. Pike
, Emily Miao
, et al.
·
Journal of Clinical Oncology
·
71
PDF
Tebentafusp for the treatment of HLA-A*02:01–positive adult patients with unresectable or metastatic uveal melanoma
2022
·
Lanyi Nora Chen
, Richard D. Carvajal
·
Expert Review of Anticancer Therapy
·
55
PDF
Efficient Trafficking of Chimeric Antigen Receptor (CAR)-Modified T Cells to CSF and Induction of Durable CNS Remissions in Children with CNS/Combined Relapsed/Refractory ALL
2015
·
Susan R. Rheingold
, Lanyi Nora Chen
, et al.
·
Blood
·
47
Neoadjuvant immunotherapy in resectable non-small-cell lung cancer
2023
·
Lanyi Nora Chen
, Alexander Z. Wei
, et al.
·
Therapeutic Advances in Medical Oncology
·
23
Characteristics and outcomes of lung cancer in solid organ transplant recipients
2020
·
Lanyi Nora Chen
, John Spivack
, et al.
·
Lung Cancer
·
18
Systematic review on the technology’s role in supporting lung cancer patients in the treatment journey
2025
·
Safa Elkefi
, Polly Wu
, et al.
·
npj Digital Medicine
·
10
Tissue and plasma-based mechanisms of resistance to first-line osimertinib in EGFR-mutant NSCLC: A multi-institutional cohort.
2023
·
Zofia Piotrowska
, Lanyi Nora Chen
, et al.
·
Journal of Clinical Oncology
·
10
Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA)
2023
·
Alexander Z. Wei
, Lanyi N. Chen
, et al.
·
Pigment Cell & Melanoma Research
·
8
PDF
Chemotherapy and Osimertinib Combination Should Be the First-Line Treatment for All Advanced EGFR+ NSCLC
2024
·
Lanyi Nora Chen
, Alexandria T.M. Lee
, et al.
·
Journal of Thoracic Oncology
·
6
Considerations for adjuvant immunotherapy in stage II melanoma: KEYNOTE-716 and beyond
2023
·
Lanyi Nora Chen
, Richard D. Carvajal
·
Annals of Translational Medicine
·
6
PDF
Characteristics of patients with EGFR-mutant non-small cell lung cancer (NSCLC) at a diverse metropolitan cancer center.
2022
·
Lanyi Nora Chen
, Benjamin Schluger
, et al.
·
Journal of Clinical Oncology
·
5
Weight loss in patients on osimertinib for metastatic EGFR-mutant non-small cell lung cancer
2024
·
Lanyi Nora Chen
, Xin Ma
, et al.
·
The Oncologist
·
4
PDF
First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors for patients with BRAF V600E -mutated metastatic non-small cell lung cancer: The FRONT-BRAF study.
2025
·
Alessandro Di Federico
, Kaiwen Wang
, et al.
·
Journal of Clinical Oncology
·
3
Survival outcomes associated with liver-directed therapies in patients with metastatic uveal melanoma.
2023
·
Michael M Caplan
, Lanyi Nora Chen
, et al.
·
Journal of Clinical Oncology
·
3
Exploring healthcare providers’ perceptions of virtual reality in lung cancer treatment preparedness: a mixed-methods feasibility study for the development of EveryBreathMatters
2025
·
Safa Elkefi
, Rongyi Wu
, et al.
·
Scientific Reports
·
2
PDF
Tyrosine kinase inhibitors with and without upfront CNS radiation for brain metastases in oncogene-driven non-small cell lung cancer (TURBO-NSCLC).
2024
·
Emily Miao
, Luke R. G. Pike
, et al.
·
Journal of Clinical Oncology
·
2
Impact of Genomic Subtype on Intracranial Outcomes in Treatment-Naive, EGFR-Mutant NSCLC With Osimertinib (IGnITE)
2026
·
Emily A. Miao
, Emily Wo
, et al.
·
Journal of Thoracic Oncology
·
1
Molecular profiling and perioperative management of inflammatory myofibroblastic tumors at a single institution.
2026
·
Harris Allen
, Lanyi Nora Chen
, et al.
·
Journal of Clinical Oncology
·
1
PDF
Unusual presentation of ROS1 rearranged metastatic non-small cell lung cancer
2024
·
Lanyi Nora Chen
, Claire Keating
, et al.
·
Respiratory Medicine Case Reports
·
1
Inflammatory Myofibroblastic Tumor: A Case Report of Neoadjuvant Alectinib and Summary of Single-Institution Molecular Data
2026
·
Harris Allen
, Lanyi Nora Chen
, et al.
·
JCO Precision Oncology
Molecular characterization and treatment patterns of lung cancer in solid organ transplant (SOT) recipients.
2026
·
Athena Tsu
, Rama Al Hamed
, et al.
·
Journal of Clinical Oncology
Impact of genomic subtype on intracranial outcomes in treatment-naive EGFR -mutant NSCLC with osimertinib (IGnITE).
2026
·
Emily Wo
, Emily Miao
, et al.
·
Journal of Clinical Oncology
Central Nervous System Metastases from Primary Lung Carcinoma: Significance of RNA Fusion Testing and Early Versus Late Metastases
2025
·
Michelle Garlin Politis
, Mahesh Mansukhani
, et al.
·
Journal of Personalized Medicine
PDF
Advancing neoadjuvant immunotherapy in non-small cell lung cancer (NSCLC): commentary on the Lung Cancer Mutation Consortium 3 trial (LCMC3)
2024
·
Lanyi N. Chen
, Bryan P. Stanifer
, et al.
·
AME Clinical Trials Review
A phase IV study of ApricityCARE program for cancer adverse events rapid evaluation to improve treatment outcomes of ethnic/racial minority patients with non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitors (ICI).
2024
·
Brian S. Henick
, Rajwanth Veluswamy
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
25
Citation count:
276
H-index:
8
I10-index:
7
Year
Topic
Type